Elderly Patients with Locally Advanced and Unresectable Non-Small-Cell Lung Cancer May Benefit from Sequential Chemoradiotherapy

Elderly Patients with Locally Advanced and Unresectable Non-Small-Cell Lung Cancer May Benefit from Sequential Chemoradiotherapy

Concurrent chemoradiotherapy is recommended for locally advanced and unresectable non-small-cell lung cancer (NSCLC), but radiotherapy alone may be used in patients that are ineligible for combined-modality therapy due to poor performance status or comorbidities, which may concern elderly patients i...

Full description

Bibliographic Details
Main Authors: Magdalena Zaborowska-Szmit, Marta Olszyna-Serementa, Dariusz M. Kowalski, Sebastian Szmit, Maciej Krzakowski
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
lung cancer
locally advanced
unresectable
sequential chemoradiotherapy
concurrent chemoradiotherapy
performance status
Online Access:https://www.mdpi.com/2072-6694/13/18/4534

Internet

https://www.mdpi.com/2072-6694/13/18/4534

Similar Items